Danone Nutricia Research

What Danone Nutricia Research does

Danone Nutricia Research is the dedicated research and innovation division of Danone S.A.'s Specialised Nutrition segment, focused on microbiome science and clinical nutrition for vulnerable patient populations. Founded as part of Danone's 1919 heritage, the division operates two global research centers dedicated to studying the gut microbiome's impact on health across life stages, with R&D presence in Liverpool (UK), Schiphol (Netherlands), and global coordination from Paris. Its core technology centers on synbiotic supplements and early-life nutrition interventions, including the EARLYFIT project investigating synbiotic supplementation for infants with cow's milk allergy and the PRESTO multicenter clinical trial, which demonstrated that six months of supplementation altered fecal metabolome with increased metabolites from infant-type Bifidobacterium species.

The business model operates as a B2B medical nutrition enterprise with revenue flowing through Food for Special Medical Purpose (FSMP) and clinical nutrition product sales to healthcare providers, pharmacies, and institutional channels. Distribution combines direct enterprise sales to hospitals and clinics, pharmacy and medical retail channels, and DACH regional wholesale (7 locations, 2,050 employees, 1,000+ products). Pricing is contract-based and not publicly disclosed. Customer segments span infants with cow's milk allergy (primary use case), patients with chronic diseases requiring specialized nutrition, and healthcare institutions seeking regulatory-compliant clinical nutrition products. The division competes in the global FSMP market ($18.4B in 2024, projected to reach $38.9B by 2033 at 8.7% CAGR) and clinical nutrition market ($13.97B in 2026, projected to $21.28B by 2033 at 6.2% CAGR) alongside Abbott and Nestlé Health Science.

Name

Danone Nutricia Research

Legal name

Danone S.A.

Website

https://danone.de

Company type

Public

Founded year

1919

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Danone Nutricia Research is the R&D division of Danone S.A.'s Specialised Nutrition segment, operating two global research centers focused on microbiome science and clinical nutrition for infants with cow's milk allergy, patients with chronic diseases, and healthcare institutions worldwide.

Ownership category

akta.pro rank

Headquarters

HQ city

Liverpool

HQ country

United Kingdom

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Food for Special Medical Purpose (FSMP): Danone Nutricia Research develops and commercializes specialized medical nutrition products for patients with specific dietary requirements due to medical conditions. Revenue is generated through product sales to healthcare institutions, pharmacies, and direct medical channels.
2. Clinical Nutrition Products: Danone competes in the global clinical nutrition market projected to grow from USD 13.97 billion in 2026 to USD 21.28 billion by 2033, focusing on pediatric and adult medical nutrition formulations.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

Danone Nutricia Research develops and commercializes specialized medical nutrition products, primarily Food for Special Medical Purpose (FSMP) formulations and clinical nutrition products designed for patients with specific dietary requirements due to medical conditions. The division operates two global research centers focused on microbiome science and conducts clinical research such as the EARLYFIT project on synbiotic supplements for infants with cow's milk allergy, generating evidence-backed nutritional formulations sold to healthcare institutions, pharmacies, and medical channels.

Product overview

Danone Nutricia Research operates as Danone's global research and innovation division focused on specialized nutrition, including early life nutrition, medical nutrition, and gut microbiome research. The company conducts clinical trials and develops nutritional formulations for infants with specific needs such as cow's milk allergies. Danone's broader product portfolio encompasses early childhood and medical nutrition (Spezialnahrung), though specific product names under Danone Nutricia Research are not detailed in the available sources. The company maintains two global research centers dedicated to microbiome research.

Differentiator

Problem solved

Functional benefit

Products and services

• Food for Special Medical Purpose (FSMP) products Specialized medical nutrition products for patients with specific dietary requirements due to medical conditions, sold to healthcare institutions, pharmacies, and direct medical channels.
• Clinical Nutrition Products Pediatric and adult clinical nutrition formulations including FDA-cleared pediatric nutritional products, sold into hospitals, clinics, and pharmacy channels worldwide.
• Spezialnahrung (Early Childhood and Medical Nutrition) DACH-region portfolio of early childhood and medical nutrition (specialized nutrition) products distributed via Danone DACH's 7-location network in Germany, Austria and Switzerland.

Quantifiable outcome

• Six months of synbiotic supplementation successfully altered fecal metabolome in CMA-affected infants, with increased metabolites from infant-type Bifidobacterium species (indolelactic acid and 4-hydroxyphenyllactic acid)

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

One partnership is on record.

• UC San Diego Center for Microbiome InnovationcoreStrategic or Co-development Partner · 11 December 2024Research collaboration partially funded by Danone Research & Innovation via the EARLYFIT project, examining the impact of synbiotic supplements on infants with cow's milk allergy. The study analyzed stool samples from the PRESTO multicenter clinical trial, contributing to understanding of fecal metabolome changes and infant-type Bifidobacterium species activity in CMA-affected infants.

Scale indicators5 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Nestlé Health Science: Global leader in clinical and medical nutrition directly named as a head-to-head competitor in pediatric FSMP, with overlapping product portfolio in infant medical nutrition and adult clinical feeding solutions.
• Mead Johnson (Reckitt): Major infant and child nutrition brand under Reckitt, including hypoallergenic and metabolic formulas directly comparable to Danone's CMA-focused specialty infant nutrition portfolio.
• Abbott Nutrition: Compete directly in pediatric FSMP and clinical nutrition, with similar FDA-cleared pediatric product lines and overlapping hospital channel presence across the same markets where Danone Nutricia Research operates.
• Perrigo Company: U.S.-listed infant nutrition and specialty nutrition company competing in the same medical infant formula category, with comparable distribution through pharmacies and medical retailers.
• Hero Group: European family-owned nutrition company with established medical and pediatric nutrition portfolio directly comparable to Danone's Specialised Nutrition offerings across infant and clinical nutrition.
• Fresenius Kabi: Global clinical nutrition and parenteral nutrition player with comparable FSMP-style product portfolio and overlapping hospital and homecare channels in Europe and globally.

Regional players

• Yili Group: China's largest dairy and infant formula producer with growing FSMP/care nutrition portfolio; regional player expanding globally and increasingly relevant in markets where Danone Nutricia Research competes.

Others

• Novonesis (formerly Chr. Hansen): Microbiome ingredient supplier providing probiotic strains (including Bifidobacterium) that are direct inputs to Danone Nutricia Research's synbiotic formulations, making it an enabling peer across the same scientific category.

Broad incumbents

• Bayer Consumer Health: Diversified healthcare and consumer health major with adjacent nutrition, supplement, and self-care products serving overlapping consumer and pharmacy channels, though not specialized in FSMP/clinical nutrition.

Emerging players

• BioGaia: Sweden-based probiotic company with extensive clinical work on Lactobacillus reuteri strains in infant gut health and allergy, overlapping with Danone Nutricia Research's synbiotic/Bifidobacterium evidence base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/rdfornutricia
• YouTubeyoutube.com/Danone
• Facebookfacebook.com/Danone
• LinkedInlinkedin.com/company/danone
• Instagraminstagram.com/lifeatdanone/?igshid=MzRlODBiNWFlZA==

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Danone Nutricia Research